Dexamethasone does not alter in vitro antibacterial efficacy of gentamicin

Michael T Drobbin1, Sean T Phelan, Patrick J Antonelli

  • 1Department of Otolaryngology, University of Florida, Gainesville, FL 32610, USA.

Abstract

Insights

Dexamethasone does not reduce gentamicin's effectiveness against Pseudomonas aeruginosa and Staphylococcus aureus. This finding supports using dexamethasone to protect against aminoglycoside-induced hearing loss.

Area of Science:

  • Microbiology
  • Pharmacology

Background:

  • Aminoglycoside antibiotics can cause ototoxicity (hearing damage).
  • Dexamethasone may mitigate aminoglycoside ototoxicity.
  • Concerns exist that dexamethasone might reduce antibiotic effectiveness.

Purpose of the Study:

  • To investigate if dexamethasone impacts gentamicin's antibacterial activity.
  • To assess gentamicin efficacy against Pseudomonas aeruginosa (PA) and Staphylococcus aureus (SA) with dexamethasone co-administration.

Main Methods:

  • In vitro microbiological assay.
  • Minimum Inhibitory Concentration (MIC) testing.
  • Tested gentamicin against multiple strains of PA and SA, with and without varying concentrations of dexamethasone.

Main Results:

  • Dexamethasone, at both high and low concentrations, did not alter the MIC of gentamicin for PA and SA strains by more than one dilution.
  • No significant decrease in gentamicin's antibacterial activity was observed in the presence of dexamethasone.

Conclusions:

  • Dexamethasone does not impair the antibacterial efficacy of gentamicin against PA and SA.
  • These results support the use of dexamethasone as a protective agent against aminoglycoside-induced ototoxicity.
  • Co-administration of dexamethasone with gentamicin is a viable therapeutic strategy.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...